The authors wish to point out that the units of CSF and plasma NFL in [Table 2](#t0005){ref-type="table"} and [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"} should be corrected to ng/L. Corrected files are republished here.

![Association between CSF and plasma NFL and concentrations of biomarkers in 8 subject groups. Panels A--B and D--F, plot concentrations of different markers for the 8 subject groups, HIV-negative controls (HIV-neg); primary HIV infection (PHI); untreated neuroasymptomatic subjects in different CD4 cell strata (Asympt); HIV-associated dementia (HAD); and subjects on suppressive antiretroviral treatment (ART). Boxes depict median and IQR, whiskers show 10--90 percentiles and '+' designate the means. Dotted horizontal lines in panels D-E show the limit of detection for HIV RNA (40 copies/mL), and in panel F the upper limit of normal for CSF neopterin (5.8 nmol/L). Panel C plot the correlation between log CSF and log plasma NFL.](gr1){#f0005}

![Association between NFL and age. Panel A displays the regression lines for age to log plasma and log CSF NFL in HIV-negative controls. Age was closely correlated with plasma NFL (r = 0.792, p \< 0.0001) and CSF NFL (r = 0.673, p = 0.002) in HIV-negative controls. Panel B shows plasma NFL and panel C CSF NFL plotted against age in four HIV-infected groups: HIV-associated dementia (HAD); untreated neuroasymtpomatic subjects (NA); subjects on suppressive antiretroviral treatment (ART); primary HIV-infection (PHI), and HIV-negative controls (HIV-neg).](gr2){#f0010}

###### 

Median (IQR) plasma NFL (left columns) and CSF NFL (right columns) concentrations in different groups.

Table 2

  Groups                          N    Plasma NFL         CSF NFL
  ------------------------------- ---- ------------------ -----------------------
  HIV negative (HIV-neg)          19   9.3 (5.9--13.1)    363 (264--487)
  Primary HIV infection (PHI)     13   11.2 (8.2--16.6)   732 (456--1288)
  Neuroasymtpomatic HIV (NA)                              
   CD4 \> 350                     19   9.0 (6.5--14.3)    488 (374--694)
   CD4 200--349                   17   9.7 (7.6--12.2)    573 (464--764)
   CD4 50--199                    19   12.1 (7.8--44.7)   640 (490--1530)
   CD4 \< 50                      20   39.6 (12.0--103)   2415 (690--4420)
  HIV-associated dementia (HAD)   11   114 (46.0--235)    16,185 (1513--43,010)
  HIV, treated-suppressed (ART)   22   11.1 (8.6--12.8)   582 (322--706)
